Project Grant F32AR084845

Award Date 9/30/25
Completion Date 5/31/28
Dollars Obligated $147K
Federal Grant Program
93.846
Assistance Type
Project Grant
Place of Performance
Pittsburgh, PA 15213, USA
Similar Awards
This federal Project Grant award from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) under CFDA 93.846 - Arthritis, Musculoskeletal and Skin Diseases Research, provides $488,782 to conduct research on the use of neuromuscular electrical stimulation (NMES) to address quadriceps weakness and atrophy following anterior cruciate ligament (ACL) injury and reconstruction. The overarching objective is to establish the mechanistic basis for how NMES can mitigate the...
This federal Project Grant award from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846), is intended to support the development of pre-operative planning software for the surgical treatment of patellar instability. The $292,954 award to Ortho Haus, LLC will fund work to generate data, validate computational models, and demonstrate proof-of-concept for a software platform that...
This Project Grant award from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846), is funding research to investigate the mechanistic links between gait biomechanics and the development of knee osteoarthritis (KOA). The $644,152 award, which runs from January 2025 to December 2029, will be used by the University of North Carolina at Chapel Hill to: 1) determine the acute in vivo...
This federal Project Grant award from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846), provides $393,883 to Wake Forest University to conduct research on muscle power as a predictor of knee osteoarthritis in at-risk females. The primary aim is to determine if baseline levels of maximal knee extensor muscle power can predict the incidence of structural knee osteoarthritis, as...
This $468,769 federal Project Grant award from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) under CFDA Program 93.846 - Arthritis, Musculoskeletal and Skin Diseases Research supports preclinical research to identify effective physical therapy and biological intervention strategies to reduce post-traumatic joint contracture (PTJC) following joint injury, particularly in the elbow. The key objectives are to: 1) Determine the optimal parameters of active...
The federal Project Grant award R56AR082872 was provided by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846). The $395,171 award to Rush University Medical Center aims to determine the in vivo chemical changes of contemporary ultra-high molecular weight polyethylene (PE) tibial liners used in total knee arthroplasty (TKA) procedures, and how these changes impact wear behavior...
This $520,154 Project Grant was awarded by the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) under the Child Health and Human Development Extramural Research program (CFDA 93.865). The grant aims to determine the effects of non-invasive brain stimulation to improve quadriceps muscle function after anterior cruciate ligament (ACL) reconstruction. The research will administer anodal transcranial direct current stimulation (tDCS) to 42 female participants...
This $556,160 Project Grant awarded by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (CFDA 93.846) aims to examine the efficacy of a rehabilitation approach called Rehabilitation with Exercise and Psychological Support (REPS) for patients who have undergone ACL reconstruction surgery. The REPS intervention integrates standard exercise rehabilitation with psychological support, including clinician training, patient education videos, and techniques like...
This $299,820 federal Project Grant award from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846), will fund a feasibility study on a telehealth-delivered mindful exercise intervention for people with knee osteoarthritis. The study aims to determine the feasibility of the mindful exercise program compared to telehealth-delivered exercise alone, as well as the feasibility of...
The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) awarded a $1,657,392 Project Grant under CFDA 93.846 (Arthritis, Musculoskeletal and Skin Diseases Research) to the University of Pittsburgh. The grant funds research to repurpose FDA-approved drugs for the treatment of osteoarthritis (OA) using high-throughput screening in microphysiological models. The project aims to define the capacity of FDA-approved drugs to reverse cartilage-driven and inflammation-driven OA...

This $147,236 federal Project Grant award was provided by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846). The funding supports a research project at the University of Pittsburgh to quantify the mechanical effects of knee bracing and assess its ability to prevent ligamentous injuries, such as to the medial collateral ligament (MCL) and anterior cruciate ligament (ACL). The research will use a robotic testing system and computational modeling to evaluate knee kinematics, stiffness, and failure behavior in native, MCL-deficient, and combined MCL/ACL-deficient knees with and without knee bracing. The results aim to provide evidence on whether knee braces can effectively prevent ligamentous injuries, which have significant clinical and economic impacts, especially in high-contact sports. The project period runs from September 30, 2025 to May 31, 2028.

Generated 8/5/25, 2:43 AM